Amicus Therapeutics Inc. (FOLD) Business Metric Overview - Stocknear

Amicus Therapeutics Inc.

NASDAQ: FOLD · Real-Time Price · USD
7.99
-0.03 (-0.37%)
At close: Sep 05, 2025, 3:59 PM
7.99
0.00%
After-hours: Sep 05, 2025, 05:34 PM EDT

Revenue by Geography

Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Non-Us Revenue 75.27M 64.08M 123.68M 85.33M 76.53M 73.03M 71.91M 65.7M 57.38M 57.44M 54.09M 51.47M 53.19M 54.54M 56.93M 53.91M 53.73M 45.55M 49.38M 47.16M 41.55M 42.75M 39.48M 33.36M 31.95M 24.98M
Non-Us Revenue Growth +17.47% -48.19% +44.95% +11.49% +4.80% +1.56% +9.44% +14.51% -0.11% +6.19% +5.09% -3.24% -2.47% -4.21% +5.61% +0.32% +17.97% -7.76% +4.71% +13.51% -2.82% +8.30% +18.34% +4.41% +27.91% n/a
United States Revenue 53.6M 40.17M 82.46M 56.19M 50.14M 37.38M 43.18M 37.8M 37.13M 28.83M 34.01M 30.22M 27.54M 24.18M 25.22M 25.64M 23.68M 20.85M 21.19M 20.28M 20.81M 17.77M 15.82M 15.41M 12.18M 9.07M
United States Revenue Growth +33.45% -51.29% +46.74% +12.07% +34.15% -13.44% +14.22% +1.81% +28.78% -15.22% +12.52% +9.74% +13.91% -4.13% -1.62% +8.27% +13.55% -1.59% +4.49% -2.54% +17.08% +12.35% +2.64% +26.52% +34.33% n/a

Operating Expense Breakdown

Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015
Selling, General, and Administrative Revenue 84.54M 91.83M 86.67M 75.11M 73.58M 88.03M 70.24M 65.65M 65.42M 73.96M 54.27M 47.27M 53.38M 58.12M 57.6M 46.11M 42.28M 46.73M 43.69M 37.85M 34.66M 40.22M 43.3M 39.68M 42.58M 44.3M 145.76M 31.87M 29.17M 27.4M 28.58M 21.65M 19.31M 19.13M 18.68M 17.47M 19.3M 15.7M 17.19M 15.37M 8.28M 6.43M
Selling, General, and Administrative Revenue Growth -7.93% +5.95% +15.39% +2.08% -16.42% +25.33% +6.99% +0.35% -11.54% +36.27% +14.81% -11.44% -8.15% +0.89% +24.93% +9.06% -9.52% +6.96% +15.42% +9.21% -13.82% -7.12% +9.12% -6.81% -3.89% -69.61% +357.42% +9.24% +6.48% -4.15% +32.03% +12.10% +0.94% +2.41% +6.94% -9.49% +22.92% -8.67% +11.84% +85.70% +28.80% n/a
Research and Development Revenue 60.85M 27.84M 30.19M 26.16M 24.68M 28.33M 35.03M 40.7M 35.15M 41.5M 63.87M 52.97M 78.32M 81.52M 85.6M 59.33M 63M 64.12M 79.29M 70.42M 69.61M 89.12M 91.91M 58.89M 70.98M 64.59M 57.22M 138.23M 34.66M 40.8M 45.81M 40.64M 31.98M 30.88M 30.63M 32.46M 18.28M 23.43M 22.63M 20.97M 17.23M 16.11M
Research and Development Revenue Growth +118.57% -7.79% +15.41% +5.98% -12.87% -19.13% -13.94% +15.80% -15.30% -35.03% +20.58% -32.37% -3.92% -4.77% +44.26% -5.83% -1.74% -19.14% +12.60% +1.16% -21.89% -3.04% +56.07% -17.03% +9.89% +12.89% -58.61% +298.81% -15.04% -10.94% +12.71% +27.06% +3.59% +0.80% -5.63% +77.54% -21.96% +3.54% +7.89% +21.68% +6.96% n/a